drugset / Trial / NCT00199134
FRAGRANCE Part A Safety: Study to Find a Genetic Signature of de Novo Resistance to Letrozole
Phase 2
Completed
49 enrolled
Jules Bordet Institute
Feculdade de Medicina da Universidade de Sao Paulo - Brasil · collabHospital de Clinicas de Porto Alegre · collabHospital do Cancer, Sao Paulo · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Find a genetic signature of de novo resistance to letrozole in adjuvant breast cancer;
Timeline
- Start
- 2004-11
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Letrozole | Other / unclassified | 2.5 mg | Oral |